Immunotherapy for breast cancer

Last medical review:

Immunotherapy helps to strengthen or restore the immune system's ability to fight cancer. This works to kill cancer cells and stop cancer cells from growing and spreading.

Immunotherapy is sometimes used to treat triple-negative breast cancer (TNBC). If you have immunotherapy, your healthcare team will use what they know about the cancer and about your health to plan the drugs, doses and schedules.

Immune checkpoint inhibitors

The immune system normally stops itself from attacking normal cells in the body by using specific proteins called checkpoints, which are made by some immune system cells. PD-1 is an immune checkpoint protein that attaches to a protein on cells called PD-L1. When PD-1 attaches to PD-L1, it turns off the body's immune response so it doesn't destroy healthy cells in our bodies. But it also means that our immune system doesn't recognize cancer cells.

Checkpoint inhibitor drugs may target either PD-1 or PD-L1 proteins. They stop the proteins from attaching to each other, and allow the immune system to recognize and destroy cancer cells. Diagnostic tests are done on breast cancer tumours to see if the cells have too much (overexpress) PD-1 or PD-L1. If the cells don't overexpress these proteins, immune checkpoint inhibitors are not used.

The following PD-1 or PD-L1 checkpoint inhibitors are used to treat TNBC.

Atezolizumab (Tecentriq, Tecentriq SQ) is used in combination with the chemotherapy drug nab-paclitaxel (Abraxane) to treat advanced or metastatic TNBC.

Pembrolizumab (Keytruda) is used:

  • in combination with chemotherapy before surgery (called neoadjuvant therapy) for high-risk early-stage TNBC
  • after surgery for TNBC by itself, and continued until the cancer stops responding
  • in combination with chemotherapy for TNBC that is metastatic or can't be removed with surgery and has not been treated yet

Side effects of immunotherapy

Side effects of immunotherapy will depend mainly on the type of drug or drug combination, the dose, how it's given and your overall health. Tell your healthcare team if you have side effects that you think might be from immunotherapy. The sooner you tell them of any problems, the sooner they can suggest ways to help you deal with them.

These are common side effects of immunotherapy for breast cancer:

Immunotherapy drugs work by blocking some of the immune system functions.This can cause a serious side effect where the immune system starts to attack organs in the body like the lungs, liver and intestines.

If you are on immunotherapy drugs, it's important to report any new side effects to your healthcare team right away. You may need to have treatment to stop your immune system from reacting to immunotherapy.

Find out more about immunotherapy

Find out more about immunotherapy. To make the decisions that are right for you, ask your healthcare team questions about immunotherapy.

Details on specific drugs change regularly. Find out more about sources of drug information and where to get details on specific drugs.

Expert review and references

  • American Cancer Society. Treatment of Triple-Negative Breast Cancer. 2022: https://www.cancer.org/.
  • Jagsir R, King TA, Lehman C, Morrow M, Harris JR, Burstein HJ. Malignant tumors of the breast. DeVita VT Jr., Lawrence TS, Rosenberg SA, eds.. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 11th ed. Philadelphia, PA: Wolters Kluwer; 2019: 79:1269–1317.
  • PDQ® Adult Treatment Editorial Board. Breast Cancer Treatment (PDQ®) – Health Professional Version. Bethesda, MD: National Cancer Institute; 2022: https://www.cancer.gov/.
  • National Comprehensive Cancer Network . NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Version 4.2022). 2022.
  • Ye F, Dewanjee S, Li Y, Jha NK, Chen ZS, et al. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Molecular Cancer. 2023: 22(1):105.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society